technetium tc 99m mertiatide has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blok, D; Drijfhout, JW; Feitsma, HI; Kooy, YM; Ossendorp, F; Vermeij, P; Welling, MM | 1 |
1 other study(ies) available for technetium tc 99m mertiatide and Cancer of Prostate
Article | Year |
---|---|
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
Topics: Binding, Competitive; Bombesin; Cell Line, Tumor; Chelating Agents; Drug Stability; Humans; Isotope Labeling; Male; Peptides; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Technetium; Technetium Tc 99m Mertiatide | 2004 |